AI summary · may contain errors
Integrated transcriptomic and proteomic analyses identify CTHRC1, ACTA1, and MSN as tissue and urine biomarkers linked to bladder outlet obstruction, with modest statistically significant concordance.
- Open access
Moving in European Urology, British Journal of Pharmacology, Applied and Environmental Microbiology, bioRxiv, Clinical Infectious Diseases, Gastroenterology, JNCI: Journal of the National Cancer Institute and Journal of Clinical Oncology.
Rebuilt
Nothing in this topic has moved yet this week.
Newest first · last 60 days
AI summary · may contain errors
Integrated transcriptomic and proteomic analyses identify CTHRC1, ACTA1, and MSN as tissue and urine biomarkers linked to bladder outlet obstruction, with modest statistically significant concordance.
AI summary · may contain errors
Activation of PSAM 4 -GlyR with varenicline in NaV1.8-Cre mice reduces chronic pelvic pain and bladder overactivity in cyclophosphamide- and LPS-induced IC/BPS models.
AI summary · may contain errors
After neoadjuvant therapy for muscle-invasive bladder cancer, radical cystectomy remains standard because clinical complete response matches true pathological complete response only about half the time.
AI summary · may contain errors
Real-time imaging in three healthy men shows ejaculation is a complex, multistage process, including a peri-verumontanum antechamber that forms during emission and guides flow.
AI summary · may contain errors
Clinical complete response after systemic therapy in muscle-invasive bladder cancer is proposed as a biomarker-like basis for sparing cystectomy in selected patients, pending rigorous validation.
AI summary · may contain errors
Mental health problems and adverse childhood experiences are common in children and adolescents with urinary incontinence, highlighting a linked psychosocial burden beyond age 5.
AI summary · may contain errors
PF-08052667, an integrin β6–targeted antibody-drug conjugate for intravesical dosing in non-muscle-invasive bladder cancer, shows enhanced in vivo efficacy with minimal systemic exposure and no systemic toxicity.
Journals this month
Topics moving, week to 17 Nov 2026
By field